High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.

Authors:
Tao S; Cui D; Cheng H; Liu X; Jiang Z and 2 more

Journal:
BMC Cancer

Publication Year: 2024

DOI:
10.1186/s12885-024-11943-1

PMCID:
PMC10860303

PMID:
38347489

Journal Information

Full Title: BMC Cancer

Abbreviation: BMC Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the datasets generated and during the current study are available in the tcga ( https://www cancer gov/ccg/research/genome-sequencing/tcga ) gene expression omnibus ( https://www ncbi nlm nih gov/geo/ ) including gse14520 and icgc database ( https://dcc icgc org/releases/current/projects )."

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the medical ethics committee of the Second Affiliated Hospital of Fuyang Normal University (NO.2023051). Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was supported by the Fuyang Normal University Horizontal Medical Research Special Cultivation Project (No. 2021HXYXZX09, No. 2021HXYXZX11)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025